Deep learning-driven de novo discovery of binders targeting the transmembrane domain of BamA
Archives of Microbiology · 2026
DOI: 10.1007/s00203-026-05218-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Microbiology, 2026. Verfasst von Minghui Du und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science and Bio-Pharmaceutics, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenhe District, Shenyang, 110016, Liaoning, China. Hauptthemen laut MEDLINE: Deep Learning, Bacterial Outer Membrane Proteins, Escherichia coli Proteins, Anti-Bacterial Agents. Die Arbeit nennt 54 Literaturangaben. Gefördert von: Natural Science Foundation of Liaoning Province.
Abstract (Originalsprache)
Antimicrobial resistance (AMR) is an escalating global health threat, with multidrug-resistant Gram-negative bacteria presenting a particularly serious clinical challenge. The unique outer membrane (OM) structure serves as a natural barrier against conventional therapeutics, so that treatment strategies become more complicated. Notably, drug development aimed at the transmembrane (TM) domains of membrane proteins remains highly limited. To overcome this bottleneck, we established an artificial intelligence (AI)-driven framework for the design and screening of BamA transmembrane (TM) domain-targeting binders. This framework employs a multi-channel convolutional neural network (DeepTM-Bind), which integrates heterogeneous protein features to achieve high predictive accuracy. Building upon this foundation, we further developed a multidimensional evaluation system to guide de novo design strategies. Using this integrated approach, binders targeting the lateral gate of BamA were successfully generated. All-atom molecular dynamics (MD) simulations within a membrane environment, combined with multiscale mechanistic analyses, confirmed the structural stability and strong binding potential of the candidate molecules, and revealed a previously unrecognized binding mode. Collectively, this study introduces an advanced computational paradigm for therapeutic design targeting TM domains and provides a promising strategy to combat multidrug-resistant Gram-negative pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Science and Bio-Pharmaceutics, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenhe District, Shenyang, 110016, Liaoning, China.
- Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang, 110016, China.
- School of Life Science and Bio-Pharmaceutics, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenhe District, Shenyang, 110016, Liaoning, China. zhao_syphu@163.com.
Förderung
- Natural Science Foundation of Liaoning Province
Zitieren
APA
Du, M., Xin, Y., Xu, B., Zhang, Y., Han, L., Ji, B., Zhao, J., & Zhao, Y. (2026). Deep learning-driven de novo discovery of binders targeting the transmembrane domain of BamA. Archives of Microbiology. https://doi.org/10.1007/s00203-026-05218-5
Vancouver
Du M, Xin Y, Xu B, Zhang Y, Han L, Ji B, et al. Deep learning-driven de novo discovery of binders targeting the transmembrane domain of BamA. Archives of Microbiology. 2026. doi:10.1007/s00203-026-05218-5
BibTeX
@article{Du2026,
author = {Du, Minghui and Xin, Yuqiao and Xu, Benao and Zhang, Yang and Han, Linjie and Ji, Bingjie and Zhao, Jian and Zhao, Yongshan},
title = {Deep learning-driven de novo discovery of binders targeting the transmembrane domain of BamA},
journal = {Archives of Microbiology},
year = {2026},
doi = {10.1007/s00203-026-05218-5}
}
EUVIMED